PHA Medical Grade: What Standards Apply (ISO 10993, FDA)?

PHA (polyhydroxyalkanoates) is drawing attention across medical supply chains as a bioplastic made from renewable feedstocks that degrades without persistent microplastic residue. One question comes first for any procurement team: what does “medical grade” mean for this material, and which standards apply?

Medical-grade biodegradable waste bags

Quick facts: what “medical grade” has to prove

  • “Medical grade” is a specification claim, not a certificate. The evidence is a biological evaluation under ISO 10993 plus a quality system behind the resin.
  • PHA is made by bacterial fermentation, so residual biomass, proteins and endotoxin are the variables that separate a medical grade from a commodity grade.
  • The device is regulated, not the polymer: FDA 510(k), De Novo or PMA in the United States; a Medical Device Licence and Medical Device Establishment Licence in Canada; EU MDR 2017/745 in Europe.
  • Documented PHA-family clearances exist (P4HB devices), but commercial medical-grade PHA supply is still narrow — verify rather than assume.
  • CliniEco Medical is a licensed medical device establishment (MDEL #35334) and applies the same documentation discipline to its PLA protective gowns.

What Does Medical Grade Mean for a Bioplastic

“Medical grade” is not a single certification. It is a threshold that separates commodity polymers, food-contact polymers, and polymers acceptable for use in or around the human body. Commodity grades are optimized for cost and processability. Food-contact grades must satisfy migration and safety limits. Medical grades must demonstrate biocompatibility, controlled impurities, and reproducible manufacturing under GMP.

For PHA (polyhydroxyalkanoates), the gap between grades is wider than for mature polymers. PHA is produced by bacterial fermentation, so the resin can carry residual biomass, proteins, endotoxins, and catalyst or solvent traces depending on the purification train. Endotoxin control matters most for materials that contact blood or tissue. A documented purification process is the difference between a resin that can be evaluated under ISO 10993 and one that cannot.

ISO 10993: The Biological Evaluation Framework

ISO 10993 is the international framework for the biological evaluation of medical devices. ISO 10993-1 takes a risk-based approach: the manufacturer plans the evaluation from the device’s materials, intended use, and duration of patient contact. It is the master standard that determines which tests apply, including:

  • ISO 10993-5: tests for in vitro cytotoxicity
  • ISO 10993-10: tests for sensitization and irritation
  • ISO 10993-11: tests for systemic toxicity
  • ISO 10993-3: tests for genotoxicity
  • ISO 10993-6: tests for local effects after implantation

Compliance is documented in a biological evaluation report covering material characterization, test selection rationale, results, and residual risk. Suppliers of medical-grade PHA resins typically share test summaries and certificates of analysis; devices built from those resins carry the full evaluation. Buyers should ask which tests were run, on which lots, and by which laboratory.

Regulatory Pathways for PHA Devices

The polymer itself is not the regulated product; the device is. A PHA-based mesh, suture, or implant follows the same pathways as any other medical device. In the United States, the FDA regulates devices by class: a 510(k) premarket notification for moderate-risk devices that can show substantial equivalence to a predicate, De Novo classification for novel low-to-moderate-risk devices without a predicate, and premarket approval (PMA) for high-risk devices. FDA’s 510(k) database records cleared products.

In Canada, the Medical Devices Regulations classify devices from Class I to Class IV by risk. A Medical Device Licence (MDL) is required for Classes II through IV, and a Medical Device Establishment Licence (MDEL) for importers and distributors. In the European Union, devices must satisfy the Medical Device Regulation (EU) 2017/745, including CE marking. Every pathway requires ISO 10993 biological evaluation data.

Medical-grade protective gown

What’s Cleared Today

Honest status: PHA-family products have cleared regulatory review, but the field is young. Poly-4-hydroxybutyrate (P4HB), a member of the PHA family, is the most advanced example. Tepha developed P4HB-based absorbable materials; FDA-cleared products such as Phasix mesh for hernia repair have been marketed for years. These are documented clearances, not projections.

Broader adoption remains early. Cleared devices built on PLA-family polymers (polyglactin 910 sutures such as Vicryl, for example) are far more numerous. Commercial medical-grade supply is still consolidating around a small number of producers. Peer-reviewed reviews track this progress closely.

How to Verify Medical Grade Claims

Procurement teams evaluating any bioplastic for medical use should request a standard set of documents:

  • ISO 10993 test summaries covering the relevant biological endpoints
  • Resin certificate of analysis with impurity and endotoxin data
  • Sterilization validation for the intended method (EtO or gamma)
  • Change notification commitments from the manufacturer

CliniEco applies the same discipline to its existing PLA supply line. Our biodegradable isolation gowns and 30-gallon biodegradable waste bags are produced from PLA resin, and we maintain traceability from resin lot to finished product while the PHA category matures. Our nitrile gloves complete the disposable line. Until medical-grade PHA supply is as documented as PLA, this checklist is the practical gate.

Which ISO 10993 tests apply to a short-contact device?

ISO 10993-1 does not hand down a fixed test list; it sets a process. The manufacturer describes the materials, the nature of the body contact and the duration, and the evaluation plan follows from that. For a short-contact device — intact skin, minutes to hours — the plan usually centres on cytotoxicity, irritation and sensitization, with chemical characterisation of the material underneath all three.

The parts most often requested are set out in the table below. The detail that separates a serious submission from a folder of certificates is the rationale: why each endpoint was included or excluded, which extract conditions were used, and what the residual risk is after the results are read together.

ISO 10993 part Endpoint Applies when
10993-1 Evaluation and testing within a risk management process Every device — this is the plan, not a test
10993-5 In vitro cytotoxicity All devices with patient or user contact
10993-10 Skin sensitization Skin contact
10993-23 Irritation (skin, eye, mucosal) Skin or mucosal contact
10993-11 Systemic toxicity Blood or tissue contact, or prolonged exposure
10993-6 Local effects after implantation Implantable devices
10993-3 Genotoxicity, carcinogenicity, reproductive toxicity Long-term or implantable contact

The list is a starting point, not a prescription: the evaluation plan for a given device selects the endpoints from its materials, contact site and duration.

Two practical notes for buyers. First, cytotoxicity is a screening test, not a pass mark for the whole material — a resin can be non-cytotoxic and still carry endotoxin that matters for a blood-contacting device. Second, results belong to a material and a manufacturing process, so a test report issued for a resin lot does not automatically transfer to a device moulded on a different line.

What documentation should a supplier hand over?

A medical-grade claim is only as good as the paperwork behind it. Ask for five documents and read them together, because each one answers a different question.

The ISO 10993 evaluation report answers whether the material is biologically acceptable for the intended contact. The resin certificate of analysis answers what is in this lot — impurity profile, residual monomers, and for fermentation-derived polymers, endotoxin where relevant. The ISO 13485 certificate answers whether the manufacturing system is controlled. The sterilization validation answers whether the intended method (EtO or gamma, for instance) leaves the device sterile without degrading the polymer. The change-notification commitment answers what happens when the resin source or process moves.

The grade ladder below shows why the first two documents matter more for PHA than for a mature polymer. Commodity PHA can be perfectly good plastic; the difference at medical grade is documented control of biological residuals.

Grade What it has to demonstrate Evidence a buyer should see Question to ask
Commodity Processability and cost; nothing about body contact Technical datasheet What is the lot-to-lot variation in impurity profile?
Food contact Migration limits for food-contact use Food-contact compliance statement Which jurisdiction's limits were tested?
Medical Biocompatibility for the intended contact, controlled impurities and endotoxin, reproducible manufacturing ISO 10993 evaluation report, certificate of analysis, ISO 13485 certificate Which tests, on which lots, run by which laboratory?

A supplier who cannot name the laboratory, the lots and the test dates has not supplied evidence. That is not an accusation — it is the standard the file has to meet when a regulator or a hospital asks.

Is medical-grade PHA available today?

Partly, and the honest answer is narrower than the marketing suggests. PHA-family materials have reached cleared devices: poly-4-hydroxybutyrate (P4HB) is the most advanced example, with absorbable devices cleared by the FDA and marketed for years. Those are documented clearances, not projections.

Commercial supply of medical-grade PHA resin remains concentrated among a small number of producers, and most PHA on the market is commodity or industrial grade. For a procurement team, that means the category is worth tracking but not yet a drop-in replacement for established polymers in every application.

The practical position is to specify what you need rather than what the material is called. If a device needs biocompatibility evidence, endotoxin control and a validated sterilization process, ask for those documents from any supplier, PHA or not, and compare like with like. Where the PHA route is not yet documented to that standard, a PLA line with traceability from resin lot to finished product is the lower-risk choice — which is the discipline CliniEco Medical applies to its PLA waste bags and PLA protective gowns today.

Regulatory pathways do not change because the feedstock is renewable. The device is what is regulated: a 510(k), De Novo or PMA in the United States depending on risk and predicate; a Medical Device Licence for Classes II to IV in Canada, with an establishment licence for importers and distributors; and conformity with the EU Medical Device Regulation 2017/745 in Europe. Every one of those routes expects biological evaluation data.

Related reading

FAQ

Is all PHA medical grade?

No. Most commercial PHA is commodity or industrial grade. Medical-grade PHA must demonstrate biocompatibility under ISO 10993, controlled endotoxin and impurity levels, and consistent manufacturing under a quality system. Grade claims should always be verified with documentation.

What is P4HB?

P4HB (poly-4-hydroxybutyrate) is a specific member of the PHA family used in absorbable medical devices. Tepha’s P4HB technology underlies FDA-cleared products including Phasix mesh for soft tissue repair. It is the most commercially advanced PHA in medical use today.

Does CliniEco sell PHA products today?

Not yet. CliniEco offers PLA-based biodegradable products, including isolation gowns and 30-gallon waste bags. We will introduce PHA products only when medical-grade supply and documentation meet our standards.

Does a medical-grade claim have to be certified by a regulator?

Not as a standalone certificate. The claim is supported by the device's regulatory file — biological evaluation, quality system and, where applicable, a device licence. A resin supplier may publish test summaries, but the device manufacturer carries the evaluation for the finished product.

Which is more advanced for medical use, PHA or PLA?

PLA-family polymers have a longer record in cleared absorbable devices, such as polyglactin sutures, and a broader supplier base. PHA-family materials have documented clearances too, but commercial medical-grade supply is narrower, so documentation is harder to compare across suppliers.

Standards work leaves a folder or it leaves an impression. The MDEL quality system SOP pack collects procedures and record forms that a quality lead can fold into a materials file.

A specification is judged by what it buys. The clinic supply planner restates consumption per site as monthly whole cases with a CAD figure the specification can be held to.

Related Reading

Explore more guides in this category:

Already working with clinics? Become a regional representative.